Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
Clinical trial NCT04467983 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04467983
- Sponsor
- Hospital for Special Surgery, New York
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2026-09-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.